|
|
Volumn 97, Issue 5, 2013, Pages 551-552
|
|
Guest Editorial: Advances in the management of acquired aplastic anemia
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALEMTUZUMAB;
CYCLOSPORIN;
HORSE THYMOCYTE ANTIBODY;
RABBIT THYMOCYTE ANTIBODY;
THROMBOPOIETIN;
THYMOCYTE ANTIBODY;
UNCLASSIFIED DRUG;
ACQUIRED APLASTIC ANEMIA;
ALLOGENIC BONE MARROW TRANSPLANTATION;
APLASTIC ANEMIA;
CHINESE;
CYTOTOXIC T LYMPHOCYTE;
DRUG EFFICACY;
EARLY DIAGNOSIS;
EDITORIAL;
EPSTEIN BARR VIRUS;
GRAFT VERSUS HOST REACTION;
HUMAN;
IMMUNOPATHOGENESIS;
IMMUNOSUPPRESSIVE TREATMENT;
LYMPHOPROLIFERATIVE DISEASE;
PATHOPHYSIOLOGY;
TREATMENT RESPONSE;
UNRELATED DONORS;
ANEMIA, APLASTIC;
HUMANS;
|
|
EID: 84878014697
PISSN: 09255710
EISSN: 18653774
Source Type: Journal
DOI: 10.1007/s12185-013-1325-9 Document Type: Editorial |
|
Times cited : (8)
|
|
References (0)
|
